Insider Selling: OrthoPediatrics Corp. (NASDAQ:KIDS) Director Sells 359 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) Director (Reynolds) Marie C. Infante sold 359 shares of OrthoPediatrics stock in a transaction dated Tuesday, September 7th. The stock was sold at an average price of $69.19, for a total transaction of $24,839.21. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

KIDS opened at $69.65 on Wednesday. The company has a market cap of $1.37 billion, a price-to-earnings ratio of -40.97 and a beta of 0.69. OrthoPediatrics Corp. has a 52-week low of $38.01 and a 52-week high of $72.50. The firm’s fifty day simple moving average is $64.46 and its two-hundred day simple moving average is $58.46.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Wednesday, August 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.21) by $0.10. The business had revenue of $26.70 million for the quarter, compared to the consensus estimate of $24.14 million. OrthoPediatrics had a negative net margin of 36.61% and a negative return on equity of 7.64%. As a group, sell-side analysts expect that OrthoPediatrics Corp. will post -0.9 earnings per share for the current fiscal year.

A number of institutional investors have recently added to or reduced their stakes in KIDS. Dimensional Fund Advisors LP increased its position in OrthoPediatrics by 13.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 79,821 shares of the company’s stock worth $3,294,000 after purchasing an additional 9,551 shares during the last quarter. Envestnet Asset Management Inc. increased its position in shares of OrthoPediatrics by 22.6% during the first quarter. Envestnet Asset Management Inc. now owns 33,231 shares of the company’s stock valued at $1,620,000 after acquiring an additional 6,123 shares during the last quarter. Paradigm Capital Management Inc. NY increased its position in shares of OrthoPediatrics by 95.2% during the first quarter. Paradigm Capital Management Inc. NY now owns 24,600 shares of the company’s stock valued at $1,199,000 after acquiring an additional 12,000 shares during the last quarter. Swiss National Bank increased its position in shares of OrthoPediatrics by 1.4% during the first quarter. Swiss National Bank now owns 29,100 shares of the company’s stock valued at $1,419,000 after acquiring an additional 400 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of OrthoPediatrics by 137.3% in the first quarter. BNP Paribas Arbitrage SA now owns 5,902 shares of the company’s stock valued at $288,000 after purchasing an additional 3,415 shares during the period. Hedge funds and other institutional investors own 76.18% of the company’s stock.

KIDS has been the subject of several research reports. Needham & Company LLC boosted their price objective on shares of OrthoPediatrics from $70.00 to $77.00 and gave the company a “buy” rating in a research report on Monday, June 14th. Piper Sandler upped their price target on shares of OrthoPediatrics from $70.00 to $80.00 and gave the stock an “overweight” rating in a research report on Thursday, August 5th. JMP Securities upped their price target on shares of OrthoPediatrics from $70.00 to $77.00 and gave the stock an “outperform” rating in a research report on Friday, August 6th. Finally, Zacks Investment Research upgraded shares of OrthoPediatrics from a “hold” rating to a “buy” rating and set a $77.00 price objective for the company in a research note on Wednesday, August 11th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $73.14.

About OrthoPediatrics

OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard.

Featured Article: Conference Calls

Insider Buying and Selling by Quarter for OrthoPediatrics (NASDAQ:KIDS)

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.